#Amarin stock conversation free

However, this figure increases on the past 10-day timeline to an average of 1.92 million.Ĭurrent records show that the company has 406.18M in outstanding shares. Elsewhere in the market, the S&P 500 Index has rallied 0.24% in last trading session, with the Dow Jones Industrial also saw a positive session on the day with 0.03%.Īn analysis of the Amarin Corporation plc (NASDAQ:AMRN) stock in terms of its daily trading volume indicates that the 3-month average is 2.80 million. (ABBV) showed down trend of -1.04% while its price kept floating at -7.98% over the past year.

(IONS) whose stock price was up 2.53% in the last trading session, and has flourished 19.86% over the past year. Another comparison is with Ionis Pharmaceuticals Inc. Turning out attention to how the Amarin Corporation plc stock has performed in comparison to its peers in the industry, here’s what we find: AMRN’s stock is 1.61% on the day and -25.00% in the past 12 months, while AstraZeneca PLC (AZN) traded 0.27% in the last session and was positioned 11.72% up on its price 12 months ago. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 50% Sell. On the technical perspective front, indicators give AMRN a short term outlook of 50% Sell on average. Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. Per this projection, the revenue is forecast to grow -14.30% below that which the company brought in 2023. Staying with the analyst view, there is a consensus estimate of $316.28 million for the company’s annual revenue in 2023. The average estimate suggests sales growth for the quarter will likely fall by -15.70% when compared to those recorded in the same quarter in the last financial year. On average, analysts have forecast the company’s revenue for the quarter will hit $79.58 million, with the likely lows of $76.4 million and highs of $82.25 million. In this case, analysts estimate an annual EPS growth of 34.60% for the year and 17.60% for the next year. Analysts tracking AMRN have forecast the quarterly EPS to shrink by -0.03 per share this quarter, while the same analysts predict the annual EPS to hit -$0.17 for the year 2023 and up to -$0.

#Amarin stock conversation free

Best of all, this upstart technology firm is currently trading undiscovered - below 25-cents per share - so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.Īll the details are in the FREE online report you can get here.Īmarin Corporation plc, which has a market valuation of $461.47 million, is expected to release its quarterly earnings report May 03, 2023. One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. 25-cent Stock Takes $11T Commodities Sector Digital